CKD: Nutrition Assessment and Best Predictors of CKD (2001)

Citation:
 
Study Design:
Class:
- Click here for explanation of classification scheme.
Quality Rating:
Research Purpose:

The purpose of this study was to determine dietary protein intake in subjects with normal kidney function compared to those with renal dysfunction.  Compliance to low protein diet instruction in predialysis subjects and high protein diet instruction for dialysis subjects was also assessed.

Inclusion Criteria:

Predialysis patients being treated by 1 of 5 nephrologists.  No criteria specified.

 

Exclusion Criteria:
Not mentioned.
Description of Study Protocol:

Recruitment

  • 89% enrolled via one nephrologist (100% of practice)
  • 11% enrolled via 4 other nephrologists (small percentage of each practice)

"Analyses showed no difference in results on the basis of treating nephrologist."

No mention of informed consent. 

Design:

1. Cross-sectional study:  Baseline data collected for analyses.

2. Nonrandomized subtrial:  Subgroup of subjects reassessed within 3 months of beginning dialysis and again 6-9 months from beginning dialysis.

Blinding used:  none mentioned - lab tests

Intervention:

1. Cross-sectional study: no intervention provided as part of this study, but all subjects were assessed to determine previous exposure to low protein diet instruction.

  • Prestudy diet intervention included physicians often assessing protein intake by dietary recall and providing advise regarding high- and low- protein foods which included materials developed by the Australian Kidney Foundation.  Dietary compliance and reinforcement was given at 3 to 6 month intervals.  Patients were referred to a dietitian if dietary compliance was unsatisfactory.
  • Dietitian intervention included measurement of BMI, assessment of protein and calorie intake (protein intakes 0.6-0.8 g/kg IBW/d and 35 kcal/kg IBW/d), nutrition counseling & follow-up in 4 wk to evaluate compliance.  Follow-up as recommended by patient, physician, dietitian.

2. Dialysis subgroup: received uniform diet counseling regarding adequate protein intake (1.2 g/kg/day for HD; 1.5 g/kg/day for CAPD) and kcal (35-45 kcal/day, with emphasis on PUFA and complex carbohydrates) at commencement of dialysis.  Diets were reviewed within one week of commencement of diaysis, again within one month, and then "as needed" or at regular 6 month intervals.  All dialysis diet counseling was received by a dietitian.

Statistical analysis

  • Statview II (Abacus Concepts, Inc., Berkeley CA)
  • Pearson correlation coefficient for correlation testing
  • Univariate and multivariate analyses to determine independent effects of study variables
  • Unpaired or paired t tests for comparisons between groups, or repeated comparisons, respectively
  • ANOVA  to detect differences between multiple groups
  • P<0.05 considered significant
Data Collection Summary:

Timing of measurements:

Baseline (total group):

  • Biochemical data: a) blood: urea, creatinine, albumin, glucose, cholesterol, and trigylcerides.  b) 24-hour urine collection: urea, creatinine, protein; data used to determine DPI. 
  • Anthropometrics: see below 
  • Diet: subjects were assessed as to whether or not they had been advised about a low-protein diet and whether the instruction had been given by a dietitian.

Dialysis subgroup (at commencement of dialysis, thereafter "as needed" or regular 6 month follow up):

  • food intake (total calories and protein requirements based on IBW, determined in this study to be BMI=25)
  • biochemistry, including albumin
  • anthropometrics
  • total body nitrogen (to reflect protein stores) 

Dependent variables

  • Estimated dietary protein intake (DPI).
  • Methods to assess daily protein intake (DPI):

    1. predialysis (method of Meroni et al, 1985): g/d = 6.25 x [UUN (g/d) + ideal body weight (kg) x 0.031] + urinary protein losses
    2. post-HD (method of Borah et al, 1978): not quoted in article
    3. post-CAPD (method of Bergstrom et al, 1993): not quoted in article

Independent variables

  • Serum creatinine
  • Dietary modification advice

Control variables:

Description of Actual Data Sample:

Initial N:

1. Baseline: N=766

2. Dialysis subgroup: N=52

Attrition (Final N):

  • 3 subjects from dialysis subgroup died within 12 wk commencement of dialysis
  • 49 dialysis subjects were reassessed at 6-11 wk commencement of treatment
  • 39 dialysis subjects were reassessed at 6-9 months from commencement of treatment

Age:  54.4±0.6 (7-88) years

Ethnicity:  not mentioned

Other relevant demographics:

Anthropometrics:  

Location:  New South Wales, Australia

Summary of Results:

Baseline data was grouped by serum creatinine for comparison (<0.12 mmol/L and >0.12 mmol/L):

  • Subjects with normal serum creatinine (<0.12mmol/L) without protein restriction had significantly higher DPI than those who had been advised to restrict protein (1.08±0.01 vs. 0.96±0.02 g/kg/d; P<0.01).
  • Subjects with elevated serum creatinine advised to follow a low protein diet had a lower DPI than those that had not received diet advise (0.87±0.02 vs 0.93±0.01 g/kg/d; P<0.05).
  • Subjects with higher serum creatinine were older, had lower BMI, and higher levels of plasma glucose and triglycerides.  Albumin was lower, but WNL.

Demographic characteristics

 

Serum creatinine

P

 

<0.12

>0.12

 
 

mmol/L

 

 

n=565

n=201

 

low protein diet

n=180

n=147 or 148

 
seen by RD prior to baseline for diet reinforcement 41/180 (23%) 93/147 (63%) na

Age, yr

51.8±0.7

61.8±1.1

<0.0001

BMI

25.7±0.2

24.2±0.3

<0.05

Albumin (g/dL)

44.8±0.1

41.7±0.2

<0.0001

Creatinine (mmol/L) 0.08±0.001 0.35±0.020 <0.0001

Urea (mmol/L)

5.6±0.1

17.7±0.7

<0.0001

CrCl (ml/min)

100.4±1.5

36.1±2.1

<0.0001

24-h urinary protein (g/d)

0.32±0.04

1.4±0.13

<0.0001

Estimated DPI (g/kg/d)

1.05±0.01

0.89±0.02

<0.0001

For all subjects at baseline, DPI correlated most strongly with CrCl, independent of prestudy diet advise (r=0.50, P<0.001), BMI (r=0.23, P<0.0001), and serum albumin (r=0.14, P<0.0001).

Dialysis subgroup:  52 subjects commenced dialysis within 3 months of baseline assessment.  47 (or 49) were reassessed 6-11 weeks after dialysis.  Despite advice on increasing dietary protein after initiation of dialysis, there was not a significant change (0.79±0.04 vs. 0.82±0.03 g/kg/d; P=0.64); however, there was a significant increase by 6 to 9 months (1.04±0.04 g/kg/d vs. both prior measurements; P<0.005).

Author Conclusion:

A low dietary protein intake in renal impairment occurs independently of dietary advice, but compliance with such advice is evident because patients advised to consume a low protein diet had significantly lower protein intake than patients receiving no dietary advice. Adaptation to a high protein intake after instigation of dialysis is unsuccessful in the short-term, irrespective of whether advice is given regarding a low protein diet before dialysis is initiated. However, 6 to 9 months after the commencement of dialysis, a significant increase in protein intake occurs which in the hemodialysis population correlates with dialysis delivery.

Funding Source:
Government: NHMRC (Australia),
University/Hospital: Royal North Shore Hospital (Australia)
Reviewer Comments:

The limitations of this study were the observational nature of the study and lack of standard protocol for nutrition counseling. Physicians provided the initial counseling prior to dialysis and only referred non-compliant patients to the dietitian. However, the dietitian saw patients at the initiation of dialysis that resulted in an increase in dietary protein by 6 to 9 months.

In this study, calculations of caloric and protein needs were based on ideal body weight, assumed to be BMI:25.

Figures published in the abstract differ slightly from figures published in the results section of this paper.

Inadequate description of subject recruitment, no details regarding confounding factors, statistical correlations may not be clinically relevant.

Quality Criteria Checklist: Primary Research
Relevance Questions
  1. Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) ???
  1. Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) ???
  2. Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? Yes
  2. Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? Yes
  3. Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice? Yes
  3. Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice? Yes
  4. Is the intervention or procedure feasible? (NA for some epidemiological studies) ???
  4. Is the intervention or procedure feasible? (NA for some epidemiological studies) ???
 
Validity Questions
  1. Was the research question clearly stated? Yes
1. Was the research question clearly stated? Yes
  1.1. Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? Yes
  1.1. Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? Yes
  1.2. Was (were) the outcome(s) [dependent variable(s)] clearly indicated? Yes
  1.2. Was (were) the outcome(s) [dependent variable(s)] clearly indicated? Yes
  1.3. Were the target population and setting specified? Yes
  1.3. Were the target population and setting specified? Yes
  2. Was the selection of study subjects/patients free from bias? ???
2. Was the selection of study subjects/patients free from bias? ???
  2.1. Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? No
  2.1. Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? No
  2.2. Were criteria applied equally to all study groups? Yes
  2.2. Were criteria applied equally to all study groups? Yes
  2.3. Were health, demographics, and other characteristics of subjects described? Yes
  2.3. Were health, demographics, and other characteristics of subjects described? Yes
  2.4. Were the subjects/patients a representative sample of the relevant population? ???
  2.4. Were the subjects/patients a representative sample of the relevant population? ???
  3. Were study groups comparable? ???
3. Were study groups comparable? ???
  3.1. Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) Yes
  3.1. Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) Yes
  3.2. Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? ???
  3.2. Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? ???
  3.3. Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.) N/A
  3.3. Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.) N/A
  3.4. If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? No
  3.4. If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? No
  3.5. If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.) No
  3.5. If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.) No
  3.6. If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? N/A
  3.6. If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? N/A
  4. Was method of handling withdrawals described? No
4. Was method of handling withdrawals described? No
  4.1. Were follow-up methods described and the same for all groups? ???
  4.1. Were follow-up methods described and the same for all groups? ???
  4.2. Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) No
  4.2. Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) No
  4.3. Were all enrolled subjects/patients (in the original sample) accounted for? Yes
  4.3. Were all enrolled subjects/patients (in the original sample) accounted for? Yes
  4.4. Were reasons for withdrawals similar across groups? ???
  4.4. Were reasons for withdrawals similar across groups? ???
  4.5. If diagnostic test, was decision to perform reference test not dependent on results of test under study? N/A
  4.5. If diagnostic test, was decision to perform reference test not dependent on results of test under study? N/A
  5. Was blinding used to prevent introduction of bias? Yes
5. Was blinding used to prevent introduction of bias? Yes
  5.1. In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? N/A
  5.1. In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? N/A
  5.2. Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) Yes
  5.2. Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) Yes
  5.3. In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? Yes
  5.3. In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? Yes
  5.4. In case control study, was case definition explicit and case ascertainment not influenced by exposure status? N/A
  5.4. In case control study, was case definition explicit and case ascertainment not influenced by exposure status? N/A
  5.5. In diagnostic study, were test results blinded to patient history and other test results? N/A
  5.5. In diagnostic study, were test results blinded to patient history and other test results? N/A
  6. Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? ???
6. Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? ???
  6.1. In RCT or other intervention trial, were protocols described for all regimens studied? Yes
  6.1. In RCT or other intervention trial, were protocols described for all regimens studied? Yes
  6.2. In observational study, were interventions, study settings, and clinicians/provider described? Yes
  6.2. In observational study, were interventions, study settings, and clinicians/provider described? Yes
  6.3. Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? Yes
  6.3. Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? Yes
  6.4. Was the amount of exposure and, if relevant, subject/patient compliance measured? ???
  6.4. Was the amount of exposure and, if relevant, subject/patient compliance measured? ???
  6.5. Were co-interventions (e.g., ancillary treatments, other therapies) described? No
  6.5. Were co-interventions (e.g., ancillary treatments, other therapies) described? No
  6.6. Were extra or unplanned treatments described? No
  6.6. Were extra or unplanned treatments described? No
  6.7. Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? ???
  6.7. Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? ???
  6.8. In diagnostic study, were details of test administration and replication sufficient? N/A
  6.8. In diagnostic study, were details of test administration and replication sufficient? N/A
  7. Were outcomes clearly defined and the measurements valid and reliable? ???
7. Were outcomes clearly defined and the measurements valid and reliable? ???
  7.1. Were primary and secondary endpoints described and relevant to the question? ???
  7.1. Were primary and secondary endpoints described and relevant to the question? ???
  7.2. Were nutrition measures appropriate to question and outcomes of concern? ???
  7.2. Were nutrition measures appropriate to question and outcomes of concern? ???
  7.3. Was the period of follow-up long enough for important outcome(s) to occur? Yes
  7.3. Was the period of follow-up long enough for important outcome(s) to occur? Yes
  7.4. Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? ???
  7.4. Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? ???
  7.5. Was the measurement of effect at an appropriate level of precision? ???
  7.5. Was the measurement of effect at an appropriate level of precision? ???
  7.6. Were other factors accounted for (measured) that could affect outcomes? No
  7.6. Were other factors accounted for (measured) that could affect outcomes? No
  7.7. Were the measurements conducted consistently across groups? ???
  7.7. Were the measurements conducted consistently across groups? ???
  8. Was the statistical analysis appropriate for the study design and type of outcome indicators? Yes
8. Was the statistical analysis appropriate for the study design and type of outcome indicators? Yes
  8.1. Were statistical analyses adequately described and the results reported appropriately? Yes
  8.1. Were statistical analyses adequately described and the results reported appropriately? Yes
  8.2. Were correct statistical tests used and assumptions of test not violated? Yes
  8.2. Were correct statistical tests used and assumptions of test not violated? Yes
  8.3. Were statistics reported with levels of significance and/or confidence intervals? Yes
  8.3. Were statistics reported with levels of significance and/or confidence intervals? Yes
  8.4. Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? N/A
  8.4. Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? N/A
  8.5. Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? Yes
  8.5. Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? Yes
  8.6. Was clinical significance as well as statistical significance reported? Yes
  8.6. Was clinical significance as well as statistical significance reported? Yes
  8.7. If negative findings, was a power calculation reported to address type 2 error? N/A
  8.7. If negative findings, was a power calculation reported to address type 2 error? N/A
  9. Are conclusions supported by results with biases and limitations taken into consideration? Yes
9. Are conclusions supported by results with biases and limitations taken into consideration? Yes
  9.1. Is there a discussion of findings? Yes
  9.1. Is there a discussion of findings? Yes
  9.2. Are biases and study limitations identified and discussed? Yes
  9.2. Are biases and study limitations identified and discussed? Yes
  10. Is bias due to study's funding or sponsorship unlikely? Yes
10. Is bias due to study's funding or sponsorship unlikely? Yes
  10.1. Were sources of funding and investigators' affiliations described? Yes
  10.1. Were sources of funding and investigators' affiliations described? Yes
  10.2. Was the study free from apparent conflict of interest? Yes
  10.2. Was the study free from apparent conflict of interest? Yes